| Health Care Providers & Services Industry | Healthcare Sector | John Huber CEO | XFRA Exchange | CA89680B2049 ISIN |
| CA Country | 5 Employees | - Last Dividend | 30 Aug 2023 Last Split | - IPO Date |
TripSitter Clinic Ltd. is a pioneering tele-health service based in Toronto, Canada, specializing in mental health treatment through virtual means. The company has developed a distinctive consultative virtual clinic that seamlessly connects patients across various U.S. states with licensed physicians. These connections are aimed at evaluating patients for a low-dose oral ketamine treatment program, specifically designed to address a range of mental health disorders. The service is accessible to individuals in an impressive array of states including, but not limited to, Arizona, California, Colorado, and New York, covering a wide spectrum of conditions such as depression, anxiety, PTSD, bipolar disorders, and OCD. TripSitter Clinic's innovative approach combines the convenience of telemedicine with the potential therapeutic benefits of ketamine, offering a contemporary solution to the pressing needs of mental health care.
The offerings of TripSitter Clinic Ltd. encompass a comprehensive treatment subscription plan that integrates various components aimed at providing holistic care for patients grappling with mental health issues. This plan is meticulously designed to ensure that patients receive the utmost care, guidance, and support throughout their treatment journey. Below is a detailed overview of the products and services provided by the company:
The comprehensive services offered by TripSitter Clinic Ltd. are tailored to meet the unique needs of each patient, ensuring a supportive, flexible, and innovative approach to mental health treatment. By leveraging the power of tele-health and the therapeutic potential of ketamine, TripSitter Clinic is at the vanguard of providing accessible and effective care for individuals suffering from mental health disorders across the United States.